58800-57-0

Usage

Uses

Used in Pharmaceutical Industry:
1,2-Di-O-acetyl-5-benzoyl-3-O-Methyl-alpha-D-ribofuranose is used as a starting material for the synthesis of various pharmaceuticals and bioactive compounds. Its unique structure allows it to be modified and incorporated into a wide range of drug molecules, making it a valuable asset in the development of new medications.
Used in Chemical Research:
1,2-Di-O-acetyl-5-benzoyl-3-O-Methyl-alpha-D-ribofuranose is used as a research compound to study its potential biological activities and interactions with biological systems. Its complex structure and chemical properties make it an interesting subject for scientific investigation, which can lead to a better understanding of its potential applications in medicine and other fields.
Used in Drug Discovery:
1,2-Di-O-acetyl-5-benzoyl-3-O-Methyl-alpha-D-ribofuranose is used in drug discovery efforts to identify new therapeutic agents and develop innovative treatments for various diseases and conditions. Its unique structure and potential to interact with biological systems make it a promising candidate for the development of novel drugs and therapies.

InChI:InChI=1/C17H20O8/c1-10(18)23-15-14(21-3)13(25-17(15)24-11(2)19)9-22-16(20)12-7-5-4-6-8-12/h4-8,13-15,17H,9H2,1-3H3

Upstream product

• 6612-91-5 ((3aR,5R,65,6aR)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)methyl benzoate 
• 6698-46-0 5-O-benzoyl-1,2-O-isopropylidene-α-D-ribofuranos-3-ulose 
• 6022-96-4 5-O-benzoyl-α-D-xylofuranose 
• 20031-21-4 1,2-O-isopropylidene-α-D-xylose 
• 532-20-7 D-xylofuranose 
• 10300-20-6 5-O-benzoyl-1,2-O-isopropylidene-3-O-methyl-α-D-ribofuranose 
• 108-24-7 acetic anhydride 
• 64-19-7 acetic acid 

Relevant academic research and scientific papers

MODIFIED CYCLIC DINUCLEOSIDE COMPOUNDS AS STING MODULATORS

Provided herein are compounds of Formula (I), Formula (II) and/or Formula (III), or pharmaceutically acceptable salts of any of the foregoing, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salt

Total synthesis of mycalisine B

The first total synthesis of the marine nucleoside Mycalisine B-a naturally occurring and structurally distinct 4,5-unsaturated 7-deazapurine nucleoside-has been accomplished in 10 linear steps with 27.5% overall yield from commercially available 1,2,3,5-tetra-O-acetyl-ribose and tetracyanoethylene. Key steps of the approach include: (1) I2 catalyzed acetonide formation from 1,2,3,5-tetra-O-acetylribose and acetone at large scale; (2) Vorbrüggen glycosylation using N4-benzoyl-5-cyano-6-bromo-7H-pyrrolo[2,3-d]pyrimidine as a nucleobase to avoid formation of N-3 isomer; (3) mild and scalable reaction conditions.

A total synthesis of mycalisine A

In this paper, we report a total synthesis of a naturally occurring pyrrolo[2,3-d]pyrimidine nucleoside, mycalisine A. Our synthetic strategy uses d-xylose as the starting material and Vorbrüggen glycosylation as the key step. Mycalisine A was synthesized in 11 steps with a 15% overall yield.